Skip to content

Industry-leading iPSC Gene Editing Technology

Get the highest precision and efficiency with Ncardia’s proprietary STAR-CRISPR technology

STAR-CRISPR far surpasses other established gene editing methodologies. 
Partner with Ncardia to: 
- Reduce unintended edits in oncogenes and coding regions
- Mitigate safety risks in iPSC genetic modifications
- Access knock-out efficiency of ~90%, surpassing Cas9 and MAD7
- Utilize knock-in efficiency up to 50%, 2-3 times higher than other methods

Power Your Research With STAR-CRISPR Technology

What to Expect From Ncardia iPSC Gene Editing Service

dd-Figure-1-2

Unmatched Efficiency

and minimal off-targets 

Streamlined Experience

With Ncardia's proprietary technology

Quick Turnaround

Get your iPSC line edited in 12-16 weeks

How Does STAR-CRISPR Measure Up?

CRISPR-based systems have two key components:
- Guide RNA (gRNA) — a short RNA sequence matching the target DNA sequence to be edited
- DNA cutting enzyme — typically Cas9 or their derivatives

Among all the CRISPR-based systems available to edit iPSCs, STAR-CRISPR stands out with:

 

Unparalleled efficiencies in gene knock-in and knock-out

 

Minimal off-target editing

Explore Related Services

 

Let's start a conversation
about your needs

As more and more drug innovators look to capitalize on the unique value only iPSCs can deliver, they look to Ncardia as their qualified collaborator to join them.

Karin, Scientist iPSC technology expert
Karen-2